Lisa Hasvold

2.3k total citations
16 papers, 615 citations indexed

About

Lisa Hasvold is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Lisa Hasvold has authored 16 papers receiving a total of 615 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Organic Chemistry and 8 papers in Oncology. Recurrent topics in Lisa Hasvold's work include Cancer-related Molecular Pathways (5 papers), HER2/EGFR in Cancer Research (4 papers) and DNA Repair Mechanisms (3 papers). Lisa Hasvold is often cited by papers focused on Cancer-related Molecular Pathways (5 papers), HER2/EGFR in Cancer Research (4 papers) and DNA Repair Mechanisms (3 papers). Lisa Hasvold collaborates with scholars based in United States, United Kingdom and Sweden. Lisa Hasvold's co-authors include Timothy R. Hightower, Karl P. Peterson, Richard C. Larock, Saul H. Rosenberg, Philip J. Merta, Jonas A. Nilsson, Ulrich Keller, Lisa M. Nilsson, Nan‐Horng Lin and Martina Rudelius and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Lisa Hasvold

15 papers receiving 596 citations

Peers

Lisa Hasvold
George M. Adjabeng United States
So Ha Lee South Korea
Aaron Kunzer United States
Jonas Lategahn Germany
Weifang Tang China
Matthew A. Marx United States
Tsann-Long Su Taiwan
Shin Iimura Japan
Kai Schiemann Germany
Muralidhar R. Mallireddigari United States
George M. Adjabeng United States
Lisa Hasvold
Citations per year, relative to Lisa Hasvold Lisa Hasvold (= 1×) peers George M. Adjabeng

Countries citing papers authored by Lisa Hasvold

Since Specialization
Citations

This map shows the geographic impact of Lisa Hasvold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Hasvold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Hasvold more than expected).

Fields of papers citing papers by Lisa Hasvold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Hasvold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Hasvold. The network helps show where Lisa Hasvold may publish in the future.

Co-authorship network of co-authors of Lisa Hasvold

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Hasvold. A scholar is included among the top collaborators of Lisa Hasvold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Hasvold. Lisa Hasvold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Sheppard, George S., Le Wang, Lisa Hasvold, et al.. (2018). Abstract 931: Discovery of ABBV-744, a first-in-class highly BDII-selective BET bromodomain inhibitor. Cancer Research. 78(13_Supplement). 931–931.
2.
Höglund, Andreas, Lisa M. Nilsson, Somsundar Veppil Muralidharan, et al.. (2011). Therapeutic Implications for the Induced Levels of Chk1 in Myc-Expressing Cancer Cells. Clinical Cancer Research. 17(22). 7067–7079. 110 indexed citations
3.
4.
Hasvold, Lisa, Le Wang, Zhan Xiao, et al.. (2008). Investigation of novel 7,8-disubstituted-5,10-dihydro-dibenzo[b,e][1,4]diazepin-11-ones as potent Chk1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(7). 2311–2315. 10 indexed citations
5.
Li, Gaoquan, Lisa Hasvold, Zhi‐Fu Tao, et al.. (2006). Synthesis and biological evaluation of 1-(2,4,5-trisubstituted phenyl)-3-(5-cyanopyrazin-2-yl)ureas as potent Chk1 kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(8). 2293–2298. 29 indexed citations
6.
Li, Qun, Akiyo Claiborne, Tongmei Li, et al.. (2004). Design, synthesis, and activity of 4-quinolone and pyridone compounds as nonthiol-containing farnesyltransferase inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(21). 5367–5370. 21 indexed citations
7.
Wang, Gary T., Xilu Wang, Weibo Wang, et al.. (2004). Design and synthesis of o-trifluoromethylbiphenyl substituted 2-amino-nicotinonitriles as inhibitors of farnesyltransferase. Bioorganic & Medicinal Chemistry Letters. 15(1). 153–158. 11 indexed citations
8.
Hasvold, Lisa, et al.. (2004). Pyridone‐Containing Farnesyltransferase Inhibitors: Synthesis and Biological Evaluation.. ChemInform. 35(9). 2 indexed citations
9.
Wang, Weibo, Qun Li, Lisa Hasvold, et al.. (2003). Discovery, SAR, synthesis, pharmacokinetic and biochemical characterization of A-192411: A novel fungicidal lipopeptide-(I). Bioorganic & Medicinal Chemistry Letters. 13(3). 489–493. 8 indexed citations
10.
Meulbroek, Jonathan A., Angela M. Nilius, Qun Li, et al.. (2003). In vivo characterization of A-192411: a novel fungicidal lipopeptide (II). Bioorganic & Medicinal Chemistry Letters. 13(3). 495–497. 1 indexed citations
11.
Hasvold, Lisa, Weibo Wang, Stephen L. Gwaltney, et al.. (2003). Pyridone-Containing farnesyltransferase inhibitors: synthesis and biological evaluation. Bioorganic & Medicinal Chemistry Letters. 13(22). 4001–4005. 64 indexed citations
12.
Tong, Yunsong, Nan‐Horng Lin, Le Wang, et al.. (2003). Discovery of potent imidazole and cyanophenyl containing farnesyltransferase inhibitors with improved oral bioavailability. Bioorganic & Medicinal Chemistry Letters. 13(9). 1571–1574. 18 indexed citations
13.
Li, Qun, Thomas J. Sowin, Akiyo Claiborne, et al.. (1999). Practical Synthesis of 2-Pyridone Core: Ethyl 8-Chloro-1-cyclopropyl-7-fluoro-9-methyl-4-oxo-4H-quinolizinone-3-carboxylate. Heterocycles. 51(6). 1345–1345. 3 indexed citations
14.
Li, Qun, Weibo Wang, Akiyo Claiborne, et al.. (1998). Synthesis and structure-activity relationships of 2-pyridones: II. 8-(Fluoro-substituted pyrrolidinyl)-2-pyridones as antibacterial agents. Bioorganic & Medicinal Chemistry Letters. 8(15). 1953–1958. 33 indexed citations
15.
Larock, Richard C., Timothy R. Hightower, Lisa Hasvold, & Karl P. Peterson. (1996). Palladium(II)-Catalyzed Cyclization of Olefinic Tosylamides. The Journal of Organic Chemistry. 61(11). 3584–3585. 231 indexed citations
16.
Larock, Richard C., Timothy R. Hightower, Lisa Hasvold, & Karl P. Peterson. (1996). ChemInform Abstract: Palladium(II)‐Catalyzed Cyclization of Olefinic Tosylamides.. ChemInform. 27(39). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by George M. Adjabeng Breakdown of academic impact, for papers by So Ha Lee Breakdown of academic impact, for papers by Aaron Kunzer Breakdown of academic impact, for papers by Jonas Lategahn Breakdown of academic impact, for papers by Weifang Tang Breakdown of academic impact, for papers by Matthew A. Marx Breakdown of academic impact, for papers by Tsann-Long Su Breakdown of academic impact, for papers by Shin Iimura Breakdown of academic impact, for papers by Kai Schiemann Breakdown of academic impact, for papers by Muralidhar R. Mallireddigari
Rankless by CCL
2026